Dental Implants as Risk Factors for MRONJ in Patients Taking Bone Modifying Agents

Choi, Junglim

doi:2022.60.1.39

J Korean Dent Assoc > Volume 60(1); 2022 > Article

Journal of Korean Dental Association 2022;60(1):39-47.
DOI: https://doi.org/10.22974/jkda.2021.60.1.004 Published online December 31, 2021.

골 대사 약물 복용 환자의 MRONJ 위험 인자로의 Implants

최정임

단국대학교 치과병원 통합치의학교실

Dental Implants as Risk Factors for MRONJ in Patients Taking Bone Modifying Agents

Junglim Choi

Department of Advanced General Dentistry, Dankook University Dental Hospital

Correspondence: Junglim Choi, Tel: +82-41-550-0821, Fax: +82-41-550-0117,
Email: jamiedent@dankook.ac.kr

Abstract

As the age of patients requiring implant treatments increases, the number of patients taking more than one type of medicine due to underlying diseases increases. In particular, bone modifying agents such as bisphosphonate bring rare but potentially fatal osteonecrosis of the jaw (ONJ), so careful attention is needed before dental treatment. For patients receiving these medications, the outcome of implants and the incidence of implant related ONJ are still unclear, causing clinicians to hesitate to treat them. Therefore, in this article, we would like to discuss the dental implants as a risk factor for the occurrence of ONJ and discuss what clinicians should consider in implant treatment for patients taking bone modifying agents by reviewing previous literatures.

Key Words: BRONJ; MRONJ; Dental implants; Risk factor